MEDX HEALTH CORP |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.09 CAD | -10.00% |
|
-5.26% | +50.00% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 11.84 | 18.91 | 18.67 | 20.23 | 14.7 | 6.433 |
| Enterprise Value (EV) 1 | 12.46 | 19.4 | 19.43 | 21.14 | 17.17 | 11.29 |
| P/E ratio | -6.79 x | -4.36 x | -5.56 x | -5.99 x | -2.71 x | -1.25 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 10.8 x | 17.4 x | 21.7 x | 38.2 x | 26.1 x | 12.6 x |
| EV / Revenue | 11.4 x | 17.8 x | 22.6 x | 39.9 x | 30.5 x | 22.1 x |
| EV / EBITDA | -8.95 x | -4.87 x | -6.41 x | -7.08 x | -3.77 x | -2.92 x |
| EV / FCF | -11.2 x | -17.1 x | -127 x | -9.24 x | -5.52 x | -6.24 x |
| FCF Yield | -8.92% | -5.86% | -0.79% | -10.8% | -18.1% | -16% |
| Price to Book | -7.88 x | -12.2 x | -6.51 x | -9.77 x | -4.05 x | -0.91 x |
| Nbr of stocks (in thousands) | 112,743 | 135,054 | 143,590 | 175,925 | 183,699 | 183,799 |
| Reference price 2 | 0.1050 | 0.1400 | 0.1300 | 0.1150 | 0.0800 | 0.0350 |
| Announcement Date | 4/30/18 | 4/30/19 | 6/12/20 | 4/28/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.093 | 1.087 | 0.8602 | 0.5301 | 0.5631 | 0.5106 |
| EBITDA 1 | -1.393 | -3.984 | -3.03 | -2.988 | -4.554 | -3.86 |
| EBIT 1 | -1.494 | -4.085 | -3.13 | -3.029 | -4.563 | -3.868 |
| Operating Margin | -136.67% | -375.64% | -363.9% | -571.52% | -810.29% | -757.61% |
| Earnings before Tax (EBT) 1 | -1.604 | -4.187 | -3.276 | -3.199 | -5.324 | -5.134 |
| Net income 1 | -1.604 | -4.187 | -3.276 | -3.199 | -5.324 | -5.134 |
| Net margin | -146.76% | -385% | -380.86% | -603.6% | -945.4% | -1,005.41% |
| EPS 2 | -0.0155 | -0.0321 | -0.0234 | -0.0192 | -0.0295 | -0.0279 |
| Free Cash Flow 1 | -1.112 | -1.138 | -0.1535 | -2.288 | -3.112 | -1.809 |
| FCF margin | -101.7% | -104.63% | -17.85% | -431.55% | -552.65% | -354.38% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/30/19 | 6/12/20 | 4/28/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.63 | 0.5 | 0.77 | 0.91 | 2.47 | 4.86 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.4502 x | -0.1243 x | -0.2527 x | -0.3048 x | -0.5433 x | -1.258 x |
| Free Cash Flow 1 | -1.11 | -1.14 | -0.15 | -2.29 | -3.11 | -1.81 |
| ROE (net income / shareholders' equity) | 96.4% | 275% | 149% | 130% | 187% | 95.9% |
| ROA (Net income/ Total Assets) | -127% | -386% | -360% | -324% | -389% | -342% |
| Assets 1 | 1.262 | 1.085 | 0.911 | 0.9888 | 1.368 | 1.499 |
| Book Value Per Share 2 | -0.0100 | -0.0100 | -0.0200 | -0.0100 | -0.0200 | -0.0400 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0 | 0.01 | 0 | 0.01 | 0.02 | - |
| Capex / Sales | 0.11% | 1% | 0.52% | 1.04% | 2.93% | - |
| Announcement Date | 4/30/18 | 4/30/19 | 6/12/20 | 4/28/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 19.19M | |
| +7.87% | 220B | |
| +6.22% | 183B | |
| +9.88% | 133B | |
| +24.44% | 107B | |
| -0.95% | 63.05B | |
| +11.88% | 51.74B | |
| +4.81% | 50.47B | |
| -0.27% | 40.91B | |
| +23.63% | 31.91B |
- Stock Market
- Equities
- MDX Stock
- Financials MedX Health Corp
